Bejerano, Gracehell May .
HRN: 25-54-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
AMPICILLIN 500MG (VIAL)
07/25/2024
08/01/2024
IV
500mg
Q6
Acute Bacterial Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes